1.070USD-2.73%Mkt Cap: 3.72M USDP/E: —Last update: 2026-05-26
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United State…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap3.72M USD
Enterprise Value-71.55K USD
Revenue (TTM)17.72M USD
Gross Profit5.46M USD
Net Income (TTM)-3.46M USD
Revenue/Share10.72 USD
Last Price1.070 USD
Fiscal Year EndMar 2025
MR QuarterDec 2025
Employees8
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.89
PEG1.08
EV/EBITDA0.03
EV/Revenue-0.00
P/S0.21
P/B0.53
EPS (TTM)-1.95
EPS (Forward)-0.56
52W Range
0.85004% of range6.920
52W High6.920 USD
52W Low0.8500 USD
Profitability
Gross Margin38.25%
Oper. Margin-15.59%
EBITDA Margin-14.84%
Profit Margin-24.20%
ROE-78.37%
ROA-25.25%
Growth
Revenue Growth22.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-88.00K USD
CapEx (TTM)80.00K USD
FCF Margin-20.17%
FCF Yield-96.15%
Net Debt-1.91M USD
Net Debt/EBITDA0.72
Balance Sheet
Debt/Equity0.07
Current Ratio2.88
Quick Ratio1.21
Book Value/Sh1.983 USD
Cash/Share1.480 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 20, 2019
Splits
Last Split1:20
Split DateAug 30, 2024
Analyst Consensus
Rating—
Target (Mean)12.00 USD
Target Range12.00 USD – 12.00 USD
# Analysts1
Ownership
Shares Out.3.47M
Float1.72M
Insiders0.57%
Institutions1.97%
Short Interest
Short Ratio2.1d
Short % Float21.66%
Short % Out.21.64%
Shares Short751.72K
Short (prev mo.)38.97K
Technical
SMA 501.832 (-41.6%)
SMA 2003.209 (-66.7%)
Beta1.28
S&P 52W Chg28.31%
Avg Vol (30d)343.78K
Avg Vol (10d)145.45K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—